All Outputs (43)

Development of a multimodal imaging probe for detecting aggressive prostate cancer (2020)
Thesis
Clarke, M. T. (2020). Development of a multimodal imaging probe for detecting aggressive prostate cancer. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4223251

This thesis reports on the synthesis, development and validation of a novel, non-toxic dual modal bio-imaging probe that targets a conformational molecular switch and relocalisation of cell surface Endo180 into endosomes that occurs during the early... Read More about Development of a multimodal imaging probe for detecting aggressive prostate cancer.

The toxic effect of cytostatics on primary cilia frequency and multiciliation (2019)
Journal Article
Filipová, A., Diaz Garcia, D., Bezrouk, A., Čížková, D., Dvořák, J., Filip, S., Sturge, J., & Šinkorová, Z. (2019). The toxic effect of cytostatics on primary cilia frequency and multiciliation. Journal of Cellular and Molecular Medicine, 23(8), 5728-5736. https://doi.org/10.1111/jcmm.14487

The primary cilium is considered as a key component of morphological cellular stability. However, cancer cells are notorious for lacking primary cilia in most cases, depending upon the tumour type. Previous reports have shown the effect of starvation... Read More about The toxic effect of cytostatics on primary cilia frequency and multiciliation.

Synthesis of super bright indium phosphide colloidal quantum dots through thermal diffusion (2019)
Journal Article
Clarke, M. T., Viscomi, F. N., Chamberlain, T. W., Hondow, N., Adawi, A. M., Sturge, J., Erwin, S. C., Bouillard, J. S. G., Tamang, S., & Stasiuk, G. J. (2019). Synthesis of super bright indium phosphide colloidal quantum dots through thermal diffusion. Communications Chemistry, 2(1), Article 36. https://doi.org/10.1038/s42004-019-0138-z

© 2019, The Author(s). Indium phosphide based quantum dots have emerged in recent years as alternatives to traditional heavy metal (cadmium, lead) based materials suitable for biomedical application due to their non-toxic nature. The major barrier to... Read More about Synthesis of super bright indium phosphide colloidal quantum dots through thermal diffusion.

The development of a multimodal imaging agent for the management of diabetes mellitus type 2 (2019)
Thesis
Garrod, A. J. (2019). The development of a multimodal imaging agent for the management of diabetes mellitus type 2. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4221898

Diabetes Mellitus is a metabolic disorder with multiple aetiologies with an estimated 422 million people with the condition, which is characterised by the chronic presence of hyperglycaemia and dysfunction in carbohydrate, protein, and fat metabolism... Read More about The development of a multimodal imaging agent for the management of diabetes mellitus type 2.

A 18F radiolabelled Zn(ii) sensing fluorescent probe (2018)
Journal Article
Price, T. W., Firth, G., Eling, C. J., Kinnon, M., Long, N. J., Sturge, J., & Stasiuk, G. J. (2018). A 18F radiolabelled Zn(ii) sensing fluorescent probe. Chemical communications : Chem comm / the Royal Society of Chemistry, 54(26), 3227-3230. https://doi.org/10.1039/c8cc00687c

A selective fluorescent probe for Zn(ii), AQA-F, has been synthesized. AQA-F exhibits a ratiometric shift in emission of up to 80 nm upon binding Zn(ii) ([AQA-F] = 0.1 mM, [Zn(ii)Cl 2 ] = 0-300 μM). An enhancement of quantum yield from Φ = 4.2% to Φ... Read More about A 18F radiolabelled Zn(ii) sensing fluorescent probe.

The synthesis and validation of multimodal PET/fluorescence zinc sensing probes as potential imaging agents for prostate cancer (2017)
Thesis
Firth, G. (2017). The synthesis and validation of multimodal PET/fluorescence zinc sensing probes as potential imaging agents for prostate cancer. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4221824

Prostate cancer (PCa) is the 2nd most common cancer worldwide for males, and the 4th most common cancer overall, accounting for 15% of all male cancers in 2012. PCa is asymptomatic in its early stages, advances in medical imaging are improving diagno... Read More about The synthesis and validation of multimodal PET/fluorescence zinc sensing probes as potential imaging agents for prostate cancer.

Investigating the biological and clinical implications of Endo180 in breast cancer (2017)
Thesis
Wang, K. (2017). Investigating the biological and clinical implications of Endo180 in breast cancer. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4222284

Endo180 is a 180 kDa type-1 transmembrane receptor that belongs to the mannose receptor family and interacts with extracellular / intracellular collagens. Endo180 expression is correlated with tumour grade, disease progression and poor prognosis in s... Read More about Investigating the biological and clinical implications of Endo180 in breast cancer.

How to study basement membrane stiffness as a biophysical trigger in prostate cancer and other age-related pathologies or metabolic diseases (2016)
Journal Article
Rodriguez-Teja, M., Breit, C., Clarke, M., Talar, K., Wang, K., Mohammad, M. A., Pickwell, S., Etchandy, G., Stasiuk, G. J., & Sturge, J. (2016). How to study basement membrane stiffness as a biophysical trigger in prostate cancer and other age-related pathologies or metabolic diseases. Journal of visualized experiments : JoVE, 2016(115), https://doi.org/10.3791/54230

Here we describe a protocol that can be used to study the biophysical microenvironment related to increased thickness and stiffness of the basement membrane (BM) during age-related pathologies and metabolic disorders (e.g. cancer, diabetes, microvasc... Read More about How to study basement membrane stiffness as a biophysical trigger in prostate cancer and other age-related pathologies or metabolic diseases.

Endo180 at the cutting edge of bone cancer treatment and beyond (2016)
Journal Article
Sturge, J. (2016). Endo180 at the cutting edge of bone cancer treatment and beyond. Journal of Pathology, 238(4), 485-488. https://doi.org/10.1002/path.4673

Skeletal bone is an attractive site for secondary tumour growth and is also home to spontaneous primary cancer. Treatment of bone metastasis is focused on limiting the vicious cycle of bone destruction with bisphosphonates or inhibition of receptor a... Read More about Endo180 at the cutting edge of bone cancer treatment and beyond.

Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces (2015)
Journal Article
Caley, M. P., King, H., Shah, N., Wang, K., Rodriguez-Teja, M., Gronau, J. H., Waxman, J., & Sturge, J. (2016). Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces. Clinical & experimental metastasis, 33(2), 151-165. https://doi.org/10.1007/s10585-015-9765-7

The diverse composition and structure of extracellular matrix (ECM) interfaces encountered by tumor cells at secondary tissue sites can influence metastatic progression. Extensive in vitro and in vivo data has confirmed that metastasizing tumor cells... Read More about Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.

AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival (2014)
Journal Article
Rodriguez-Teja, M., Gronau, J. H., Breit, C., Zhang, Y. Z., Minamidate, A., Caley, M. P., McCarthy, A., Cox, T. R., Erler, J. T., Gaughan, L., Darby, S., Robson, C., Mauri, F., Waxman, J., & Sturge, J. (2015). AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival. Journal of Pathology, 235(4), 581-592. https://doi.org/10.1002/path.4485

Biomechanical strain imposed by age-related thickening of the basal lamina and augmented tissue stiffness in the prostate gland coincides with increased cancer risk. Here we hypothesized that the structural alterations in the basal lamina associated... Read More about AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.

LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression (2014)
Journal Article
Mura, M., Hopkins, T. G., Michael, T., Abd-Latip, N., Weir, J., Aboagye, E., Mauri, F., Jameson, C., Sturge, J., Gabra, H., Bushell, M., Willis, A. E., Curry, E., & Blagden, S. P. (2015). LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene, 34(39), 5025-5036. https://doi.org/10.1038/onc.2014.428

RNA-binding proteins (RBPs) bind to and post-transcriptionally regulate the stability of mRNAs. La-related protein 1 (LARP1) is a conserved RBP that interacts with poly-A-binding protein and is known to regulate 5′-terminal oligopyrimidine tract (TOP... Read More about LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression.

Survival outcome and EMT suppression mediated by a lectin domain interaction of Endo180 and CD147 (2014)
Journal Article
Rodriguez-Teja, M., Gronau, J. H., Minamidate, A., Darby, S., Gaughan, L., Robson, C., Mauri, F., Waxman, J., & Sturge, J. (2015). Survival outcome and EMT suppression mediated by a lectin domain interaction of Endo180 and CD147. Molecular cancer research, 13(3), 538-547. https://doi.org/10.1158/1541-7786.mcr-14-0344-t

Epithelial cell-cell contacts maintain normal glandular tissue homeostasis, and their breakage can trigger epithelial-to-mesenchymal transition (EMT), a fundamental step in the development of metastatic cancer. Despite the ability of C-type lectin do... Read More about Survival outcome and EMT suppression mediated by a lectin domain interaction of Endo180 and CD147.

Secondary bone tumors in prostate cancer: New treatments on the horizon (2013)
Book Chapter
Sturge, J. (2013). Secondary bone tumors in prostate cancer: New treatments on the horizon. In M. Berhouma (Ed.), Bone tumors: Symptoms, diagnosis and treatment (145-175). Nova Science Publishers

Secondary bone tumors associated with the advancement of solid tumors of the prostate and other tissue sites result in the increased risk of intractable bone pain, pathological skeletal fracture and spinal-cord compression. In addition to increasing... Read More about Secondary bone tumors in prostate cancer: New treatments on the horizon.

Corrigendum (2013)
Journal Article
Waxman, J., Cobb, J. P., Palmieri, C., Rhim, J. S., Pchejetski, D., Mauri, F., Sandison, A., Fonseca, A. V., Rodriguez-Teja, M., Adamarek, A., Gronau, J. H., Kogianni, G., Caley, M. P., & Sturge, J. (2013). Corrigendum. Journal of Pathology, 229(3), e4-e4. https://doi.org/10.1002/path.4156

MRC2 (2012)
Book Chapter
Gronau, J. H., Isacke, C. M., & Sturge, J. (2012). MRC2. In S. Choi (Ed.), Encyclopedia of Signaling Molecules (1119-1123). Springer. https://doi.org/10.1007/978-1-4419-0461-4_79

Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer (2012)
Journal Article
Palmieri, C., Caley, M. P., Purshouse, K., Fonseca, A.-V., Rodriguez-Teja, M., Kogianni, G., Woodley, L., Odendaal, J., Elliott, K., Waxman, J., & Sturge, J. (2013). Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer. The British Journal of Cancer, 108(1), 163-169. https://doi.org/10.1038/bjc.2012.540

Background:Endo180 (CD280; MRC2; uPARAP)-dependent collagen remodelling is dysregulated in primary tumours and bone metastasis. Here, we confirm the release and diagnostic accuracy of soluble Endo180 for diagnosing metastasis in breast cancer (BCa).M... Read More about Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer.

Abstract P2-02-03: the collagen receptor Endo180: a metastatic plasma marker in breast cancer modulated by bisphosphonate treatment (2012)
Presentation / Conference Contribution
Sturge, J., Caley, M., Purshouse, K., Fonseca, A.-V., Rodriguez-Teja, M., Kogianni, G., Waxman, J., & Palmieri, C. (2012, December). Abstract P2-02-03: the collagen receptor Endo180: a metastatic plasma marker in breast cancer modulated by bisphosphonate treatment. Presented at Abstracts: Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 4‐8, 2012; San Antonio, TX

Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells (2012)
Journal Article
Ramasamy, K., Khatun, H., Macpherson, L., Caley, M. P., Sturge, J., Mufti, G. J., Schey, S. A., & Calle, Y. (2012). Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells. British journal of haematology, 157(5), 564-579. https://doi.org/10.1111/j.1365-2141.2012.09103.x

The response of the tumour microenvironment to anti-cancer drugs can influence treatment efficacy. Current drug-screening methodologies fail to distinguish and quantify simultaneously the concomitant effect of drugs on the tumour stroma and cancer ce... Read More about Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells.

Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection (2012)
Journal Article
Nunes, J., Naymark, M., Sauer, L., Muhammad, A., Keun, H., Sturge, J., Stebbing, J., Waxman, J., & Pchejetski, D. (2012). Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection. The British Journal of Cancer, 106(5), 909-915. https://doi.org/10.1038/bjc.2012.14

Background: Current markers available for screening normal populations and for monitoring prostate cancer (PCa) treatment lack sensitivity and selectivity. Sphingosine-1-phosphate (S1P) is a circulating lipid second messenger involved in cell growth... Read More about Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection.